MedAware Systems, Inc.

Broomfield, CO 80020, US

MedAware Systems is a next generation medical data and analytics company that solved the problem of rapid access and analysis of all available data from clinical trials research, regulatory event reporting databases, and social media.

MedAware Systems is a growth-stage company that rapidly ingests 100% of medical research and post market surveillance data to determine the safety and efficacy of medical products. We serve a $500+ billion medical device market and a $1+ Trillion Pharma market worldwide.

MedAware Systems created a patent-pending combination of AI and human intelligence (Advanced Intelligence™) to modernize how published medical science and post market surveillance data are accessed and analyzed.

Our Science of Health Informatics (SOHInfo) application rapidly and accurately collects, curates, and analyzes available safety and efficacy data for drugs, devices, diseases, or medical conditions, granular to specific patient cohorts and application settings.

The Company’s revenue model consists of three closely related services that provide unparalleled business and scientific insight and understanding through the analysis of massive data sets.

Literature and Event Surveillance (subscription service) – Proprietary, AI-Based surveillance software scrapes government event-reporting databases and automatically identifies relevant published articles from the published medical literature. Surveillance of Social Media is also included. Customers instantly access complete intelligence on reported events (malfunction, injury, and death) for their and their competitors’ products.

Data Service (subscription service) – Our AI-Based literature curation process identifies every relevant article (hundreds to tens-of-thousands) and extracts all the data contained in them to create massive analytic databases. Customers have the entirety of available evidence on safety and efficacy for theirs and their competitors’ products.

Meta-Analysis Reports (project service) – Best-in-class meta-analyses, powered by the most complete and comprehensive data available, are rapidly delivered. These reports are interactively managed to provide for customer inputs throughout the process.

General Information


Social Links

Company Industry

Select Industry:

Company Description

0 / 250
0 / 2000


Prior Year Revenue Current Year Revenue Next Year Revenue
Company Age Employees Sub-Industry
8 years, 2 months 26 Healthcare Information Services

Company Financials

Viewable by EquityNet investors only

Company Age & Size


Products / Services

0 / 1000
Creating significant value for healthcare providers, patients, suppliers, and payers

Based on the life’s work of Founder and Chief Science Officer, Dr. Zung Vu Tran, one of world’s leading medical bio-statisticians, this subscription-based and custom report service will eliminate today’s time-consuming and inaccurate keyword searches with precise database queries based on patient specific, disease specific filters, and treatment specific filters.

The Company provides accurate analysis of data across tens, hundreds, or thousands of studies, and reports that information in a standardized and quickly understood format, at a button click.

The end result is that users have the ability to “read” tens, hundreds, or thousands of research studies in less than a minute. The reports generated offer the most comprehensive and granular scientific evidence on the efficacy of disease treatment for the specific patient as well as evidence of safety and efficacy


0 / 1000
Chief Science/Scientist
Dr. Zung Vu Tran

Dr. Tran was recently Research Professor of Biostatistics, Colorado School of Public Health, and Clinical Professor of Pediatrics, School of Medicine, University of Colorado, Anschutz Medical Campus. He has also served as Interim Director, Biostatistics & Data Management Core, University of Colorado Cancer Center, and Scientific Director, Biostatistics & Data Management Core, Children’s Hospital of Philadelphia.

Dr. Tran brings over 30 years’ experience in pharmaceutical and medical device industry settings. He is recognized as a leading authority in meta-analysis methodology. As a pioneer in this science of data extraction, integration and analysis, he was the first to publish a meta-analysis in the prestigious Journal of the American Medical Association. Dr. Tran was also the first scientist to receive a NIH R01 grant for developing and applying meta-analysis methodology. He specializes in the design and analysis of clinical trials, and management of large research databases.

Chief Executive Officer
Michael Willis

Michael has served in leadership positions for technology companies for over 30 years and has considerable experience and expertise developing technology products and services for a variety of markets. With a focus on product development, sales, marketing, and customer support he has built successful companies and led them to exit strategies that brought considerable value to investors and other stakeholders.

He was CEO at publicly traded Tombstone technologies; President of Digital Creators, which was acquired by TeleTech; Group Vice President for Production and Development for Jones Digital Century, a division of Jones Intercable, then the 5th largest cable company in the US; and the Vice President for Production for Philips Interactive Media, a division of Philips Electronics.

Chief Financial Officer
Neil A. Cox

Neil has more than three decades experience in the securities and financial industry. He brings a solid understanding of acquisitions, strategic planning, private and public financing.

He was the founder and served as CFO for Tombstone Technologies, a publicly traded software company developing SaaS software systems for the printing industry and acquired by Hunt Global Resources in 2010.

Neil founded, served as CFO and was instrumental in the financing and guidance process in making the company become publicly traded. The software company helped pioneer computerized medical records on the Internet. Its software was leading edge by using an interactive website that allowed for developing complete medical histories viewable on demand by health care providers.

Neil worked as an Investment Banker and was the owner of Rocky Mountain Securities & Investments, Inc. for over 20 years.



Funding Goal$2,000,000

Funding Raised So Far$2,000,000

Funding Commitments$0

Funding Remaining$0

Funding TypeEquity

Pre-Money Valuation

Investor Ownership

Interest / Dividend

Previous Funding

General Funding


Showing your General Funding information publicly may constitute general solicitation. General solicitation is a new commonly-used way for companies to raise funding. To learn about general solicitation, consult your legal counsel. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors.

Private Funding

Viewable by EquityNet investors only


Complete a Business Plan in EquityNet

Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Investors prefer an EquityNet business plan. Entering a plan is highly educational and improves your appeal to investors.

Upload Documents

Document file names will be viewable by EquityNet investors and business supporters only. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab.

Share Your Public Profile Page

Users who follow all these tips increase their fundraising odds substantially.

  • Email your public page to all your LinkedIn contacts.
    • Post your page to your LinkedIn profile page.
  • Email your public page to all your Facebook contacts.
    • Post your page to your Facebook profile page.
  • Email your public page to all your Twitter contacts.
    • Post your page to your Twitter profile page.
  • Put your public page up on your website.
    • Don't have a website yet? Use this page as your site!
  • Share your page link anywhere there's a listing for your company.
    • Press Releases, Crunchbase, Wikipedia, Blogs, etc...
  • Email your public page to all your email contacts.
    • Use Outlook, Gmail, Yahoo Mail, Hotmail, etc...

Your Public Profile Page:

Would you like to share your public profile page with your email contacts?